Michael Walker
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AstraZeneca at 36.5% of the total.
Across 179 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Boehringer Ingelheim$688
- Novo Nordisk$553
- GSK$377
- Amgen$91
- Lilly USA, LLC$66
- plus $274 from 8 others
What the payments were for
- Food & beverage$3,220100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $1,178 |
| Boehringer Ingelheim | 36 | $688 |
| Novo Nordisk | 28 | $553 |
| GSK | 28 | $377 |
| Amgen | 5 | $91 |
| Lilly USA, LLC | 4 | $66 |
| Abbott | 3 | $59 |
| Dexcom, Inc. | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Merck | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
How this compares
$3,227 in reported general payments places this provider in the 80th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 230 | $247,861 |
| JardianceEmpagliflozin | 230 | $183,971 |
| FarxigaDapagliflozin Propanediol | 112 | $82,059 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 90 | $65,908 |
| EliquisApixaban | 65 | $53,278 |
| Tresiba Flextouch U-200Insulin Degludec | 68 | $50,562 |
| XifaxanRifaximin | 15 | $45,948 |
| LinzessLinaclotide | 50 | $37,607 |
| TradjentaLinagliptin | 44 | $34,257 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $32,572 |
| MounjaroTirzepatide | 28 | $29,660 |
| VascepaIcosapent Ethyl | 55 | $28,699 |
| TrulicityDulaglutide | 26 | $28,684 |
| EntrestoSacubitril/Valsartan | 26 | $22,982 |
| XareltoRivaroxaban | 13 | $14,472 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $553 | $247,861230 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Stiolto Respimat | $688 | $229,339298 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $1,178 | $133,787202 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $377 | $73,326106 claims |
| Lilly USA, LLCMounjaro, Trulicity | $66 | $58,34454 claims |
| MerckLagevrio (Eua), Januvia, Janumet | $20 | $38,03745 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 233 medical providers in West Virginia.
Other medical in Welch
- Joshua HopkinsWelch$4K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.